SPY768.35−0.39%QQQ738.38−0.82%BTC/USD83,375.77−1.27%DIA515.04−0.47%GLD380.75−3.22%TLT78.78−0.68%
Benzinga

Alnylam Pharmaceuticals Inc (ALNY) Stock Price, Quote, News & History

ALNYNASDAQ
Trade with Public
Trade with Public
$249.15
-6.81-2.66%
Last update: Sep 28, 10:02 AM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Alnylam Pharmaceuticals (ALNY) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$256.28
Close
-
Volume / Avg.
118.96K / 1.81M
Day Range
$250.00 - $256.60
52 Wk Range
197.81 - 495.55
Market Cap
$33.34B
P/E Ratio
44.59
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
7.16%
Days to Cover
4.13

Recent Alnylam Pharmaceuticals, Inc. News

Biotech Is Booming, But These 2 Stocks Missed the Memo

The iShares Biotechnology ETF is trading at new highs and 18 out of its top 20 constituents are green for the year.
Erica Kollmann

This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top analysts change outlook on ALNY, AGMB, BMRN, BEKE, and IONS with ratings and price targets. Check out opinions and coverage on Benzinga.
Avi Kapoor

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Alnylam cut its 2026 sales outlook despite a Q2 earnings beat as slower ATTR-CM market growth weighed on expectations and investors reacted.
Vandana Singh

Stock Market Today: Microsoft Ignites Chip Rebound as SanDisk Jumps 24%

Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance miss and a 19-year high in 30-year yields capped the rebound.
Piero Cingari

Gold Surges 3%; Bristol-Myers Squibb Earnings Top Views

US stocks gain, Dow up 300 points as tech shares surge 5.3%, Bristol-Myers Squibb beats expectations, Columbus McKinnon and Xerox report strong earnings.
Avi Kapoor
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
911.81M
Investing Cash Flow (TTM)
74.94M
Financing Cash Flow (TTM)
-377.00M
Free Cash Flow (TTM)
819.87M
Capital Expenditure (TTM)
-91.95M
Net Change in Cash (TTM)
609.75M

Analyst Trends and Forecast

2
Jun
10
3
Jul
6
1
Aug
2
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$32.21B
PE Ratio (TTM)
44.59
PE Ratio (FWD)
20.04
PEG Ratio (TTM)
0.33
PS Ratio (TTM)
7.39
PB Ratio (TTM)
25.29
Earnings Yield % (TTM)
2.24%
Earnings Yield % (FWD)
4.99%
EV / EBITDA (TTM)
29.14
Price / EBITDA (TTM)
32.13
Price / Free Cash Flow (TTM)
43.31
Book Value / Share
$10.12

Company Debt

Total Debt
$1.01B
LT Debt
$1.01B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$1.71B
Debt to Equity
0.94
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$256.28
Close
-
Volume / Avg.
118.96K / 1.81M
Day Range
$250.00 - $256.60
52 Wk Range
197.81 - 495.55
Market Cap
$33.34B
P/E Ratio
44.59
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
7.16%
Days to Cover
4.13

About

Sector
Health Care
Industry
Biotechnology
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi thera...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Alnylam Pharmaceuticals (ALNY) stock?

A

You can purchase shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Alnylam Pharmaceuticals (ALNY) competitors?

Q

What is the forecast, or price target, for Alnylam Pharmaceuticals (ALNY) stock?

A

Alnylam Pharmaceuticals has a consensus price target of $418.63.

Q

What is the current price for Alnylam Pharmaceuticals (ALNY)?

A

The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $249.15 last updated September 28, 2026 at 10:02 AM EDT.

Q

Does Alnylam Pharmaceuticals (ALNY) pay a dividend?

A

There are no upcoming dividends for Alnylam Pharmaceuticals.

Q

When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?

A

Alnylam Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Alnylam Pharmaceuticals (ALNY) going to split?

A

There is no upcoming split for Alnylam Pharmaceuticals.

Q

What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

A

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved